Diagnostic work-up in patients with possible asthma referred to a university hospital

Article English OPEN
Backer, Vibeke ; Sverrild, Asger ; Ulrik, Charlotte Suppli ; Bødtger, Uffe ; Seersholm, Niels ; Porsbjerg, Celeste (2015)
  • Publisher: Co-Action Publishing
  • Journal: European Clinical Respiratory Journal, volume 2 (eissn: 2001-8525)
  • Related identifiers: pmc: PMC4629726, doi: 10.3402/ecrj.v2i0.27768, doi: 10.3402/ecrj.v2.27768
  • Subject: airway hyperresponsiveness | spirometry | Original Research Article | reversibility | specificity | Asthma management | sensitivity | diagnostic tools | Asthma management; diagnostic tools; airway hyperresponsiveness; spirometry; reversibility; sensitivity; specificity
    mesheuropmc: respiratory tract diseases

Objective: The best strategy for diagnosing asthma remains unclear. Accordingly, the aim of this study was to evaluate diagnostic strategies in individuals with possible asthma referred to a respiratory outpatient clinic at a university hospital.Methods: All individuals with symptoms suggestive of asthma referred over 12 months underwent spirometry, bronchodilator reversibility test, Peak expiratory flow rate (PEF) registration, and bronchial challenge test with methacholine and mannitol on three separate days. The results of these tests were compared against an asthma diagnosis based on symptoms, presence of atopy and baseline spirometry made by a panel of three independent respiratory specialists.Results: Of the 190 individuals examined, 63% (n=122) were classified as having asthma. Reversibility to β2-agonist had the lowest sensitivity of 13%, whereas airway hyperresponsiveness to methacholine had the highest (69%). In contrast, specificity was the highest for reversibility testing (93%), whereas methacholine had the lowest specificity (57%). The combination of reversibility, peak-flow variability, and methacholine yielded a cumulative sensitivity of 78%, albeit a specificity of 41%. In comparison, a combination of reversibility and mannitol resulted in a specificity of 82% and a sensitivity of 42%.Conclusion: In this real-life population, different diagnostic test combinations were required to achieve a high specificity for diagnosing asthma and a high sensitivity, respectively: Our findings suggest that the diagnostic test approach should be based on whether the aim is to exclude asthma (high sensitivity required) or confirm a diagnosis of asthma (high specificity required).Keywords: Asthma management; diagnostic tools; airway hyperresponsiveness; spirometry; reversibility; sensitivity; specificity(Published: 7 July 2015)Citation: European Clinical Respiratory Journal 2015, 2: 27768 - http://dx.doi.org/10.3402/ecrj.v2.27768
  • References (31)
    31 references, page 1 of 4

    1. Thomsen SF, Ulrik CS, Kyvik KO, Larsen K, Skadhauge LR, Steffensen I, et al. The incidence of asthma in young adults. Chest. 2005; 127: 1928 34.

    2. To T, Stanojevic S, Moores G, Gershon AS, Bateman ED, Cruz AA, et al. Global asthma prevalence in adults: findings from the cross-sectional world health survey. BMC Pub Health. 2012; 12: 204.

    3. Nolte H, Nepper-Christensen S, Backer V. Unawareness and undertreatment of asthma and allergic rhinitis in a general population. Respir Med. 2006; 100: 354 62.

    4. Lund TK, Pedersen L, Anderson SD, Sverrild A, Backer V. Are asthma-like symptoms in elite athletes associated with classical features of asthma? Br J Sports Med. 2009; 43: 1131 5.

    5. Cockcroft DW, Davis BE. Diagnostic and therapeutic value of airway challenges in asthma. Curr Allergy Asthma Rep. 2009; 9: 247 53.

    6. Backer V, Harmsen L, Lund T, Pedersen L, Porsbjerg C, Rasmussen L, et al. A 3-year longitudinal study of asthma quality of life in undiagnosed and diagnosed asthma patients. Int J TubercLung Dis. 2007; 11: 463 9.

    7. Swanney MP, Ruppel G, Enright PL, Pedersen OF, Crapo RO, Miller MR, et al. Using the lower limit of normal for the FEV1/FVC ratio reduces the misclassification of airway obstruction. Thorax. 2008; 63: 1046 51.

    8. Reddel HK, Taylor DR, Bateman ED, Boulet LP, Boushey HA, Busse WW, et al. An official American Thoracic Society/ European Respiratory Society statement: asthma control and exacerbations: standardizing endpoints for clinical asthma trials and clinical practice. Am J Respir Crit Care Med. 2009; 180: 59 99.

    9. Boulet L-P, FitzGerald JM, Levy ML, Cruz AA, Pedersen S, Haahtela T, et al. A guide to the translation of the Global Initiative for Asthma (GINA) strategy into improved care. Eur Respir J. 2012; 39: 1220 9.

    10. Juniper EF, Bousquet J, Abetz L, Bateman ED. Identifying 'well-controlled' and 'not well-controlled' asthma using the Asthma Control Questionnaire. Respir Med. 2006; 100: 616 21.

  • Metrics
    No metrics available
Share - Bookmark